Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

Showing 94 results

Search by release date:: Jan, 2020 ～ Dec, 2020

December 17, 2020
Otsuka Holdings

Otsuka Health Comic Library Celebrates 30 Years Revamped website aims to further contribute to children’s health
December 17, 2020
Taiho Pharmaceutical

Taiho Pharmaceutical Concludes Licensing of Automated PDPS Platform with PeptiDream
December 17, 2020
Otsuka Pharmaceutical

Formation of a Licensing Agreement Covering Japan and Europe for the Lupus Nephritis Drug "Voclosporin"
December 10, 2020
Otsuka Holdings

Otsuka Announces Results of Two International Clinical Studies in Patients with Treatment Resistant Hypertension and Breakthrough Device Designation for ParadiseTM Ultrasound Renal Denervation System for Uncontrolled Hypertension
December 10, 2020
Otsuka Medical Devices

Otsuka Announces Results of Two International Clinical Studies in Patients with Treatment Resistant Hypertension and Breakthrough Device Designation for ParadiseTM Ultrasound Renal Denervation System for Uncontrolled Hypertension
December 10, 2020
Otsuka Pharmaceutical

Otsuka Pharmaceutical Signs On as "B. League Supporting Company" -To cooperate with physical conditioning and regional healthcare-related initiatives-
November 26, 2020
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches ENEFLUID Injection, the amino acid, glucose, electrolyte, fat, and water-soluble vitamin injection
November 16, 2020
Otsuka Pharmaceutical

UL·OS Medicated Scalp Shampoo and Medicated Skin Wash to Appear in New Packaging
November 12, 2020
Taiho Pharmaceutical

Taiho and Lung Therapeutics Enter into an Exclusive License Agreement in Japan for LTI-01, Treatment for Loculated Pleural Effusions
October 30, 2020
Otsuka Pharmaceutical

Quick NaviTM Rapid Diagnostic Test in Japan Now Supports Simultaneous Testing for Influenza and COVID-19 Through Collection of a Single Testing Sample
October 20, 2020
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory concludes a comprehensive collaborative agreement with Imizu City, Toyama
October 16, 2020
Taiho Pharmaceutical

Taiho Pharmaceutical Supports Employees' Efforts to Quit Smoking
October 15, 2020
Otsuka Pharmaceutical

Otsuka and its subsidiary Astex announce results of phase 3, ASTRAL-2 and ASTRAL-3 trials of guadecitabine in patients with previously treated AML and MDS/CMML
October 15, 2020
Otsuka Pharmaceutical

Debut of InnerSignal Skin Care Brand Outside Japan- Launched in South Korea as Functional Cosmetics with Two Key Benefits -
October 12, 2020
Otsuka Pharmaceutical

Positive Top-Line Results in Phase 3 Trial of OPC-61815, a V2 -Receptor Antagonist for the Treatment of Cardiac Edema
October 5, 2020
Otsuka Pharmaceutical

Quick NaviTM-COVID 19 Ag Rapid Diagnostic Test in Japan Now Enables Test Sample Collection from Front of Nasal Cavity
October 1, 2020
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory receives the Good Design Award 2020 for its Oral Rehydration Solution OS-1 Series
September 30, 2020
Otsuka Holdings

Otsuka Group Acquires ISO 14001 Certification -Reinforcement of group-wide environmental initiatives-
September 29, 2020
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory introduces a self-consuming solar power generation facility that contributes to CO2 emission reductions to its Kushiro Factory
September 28, 2020
Otsuka Pharmaceutical

Otsuka Has Filed an Application in Japan for Approval of Difamilast (OPA-15406) as an Atopic Dermatitis Drug
September 25, 2020
Otsuka Holdings

Otsuka’s ABILIFY MAINTENA approved for the additional indication of bipolar I disorder in Japan
September 25, 2020
Otsuka Pharmaceutical

Otsuka's ABILIFY MAINTENA approved for the additional indication of bipolar I disorder in Japan
September 24, 2020
Taiho Pharmaceutical

Taiho Pharmaceutical and MD Anderson announce collaboration to accelerate development of novel therapies for brain metastasis and other unmet medical needs
September 18, 2020
Otsuka Pharmaceutical

- Creating a Society that Supports Ongoing Employee Health -Full-scale launch of "Kenko Shacho" community website connecting corporate leaders
September 11, 2020
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches VISCOCLEAR, gel to secure the visual field that is used for the endoscope for natural opening
September 10, 2020
Otsuka Pharmaceutical

Smart Nutrition for New Lifestyles Announcing SOYJOY Green Tea & Macadamia Moist Texture Highlights the Mellow Astringency and Savor of Green Tea
September 7, 2020
Otsuka Pharmaceutical

Otsuka Pharmaceutical Supports High School Students in Summer 2020 Supporting events across Japan that are close to their hearts, including alternative athletic competitions
September 4, 2020
Otsuka Foods

Otsuka Foods Enters Partnership Agreement with Aomori Prefecture on Health Literacy Enhancement
September 4, 2020
Taiho Pharmaceutical

Taiho Pharmaceutical Adds New Orange and Lychee Flavors to the Pitas Throat Troche Lineup
September 3, 2020
Otsuka Holdings

Top-line Results fromGlobal Phase 3 Program of Vadadustat, a Drug Candidate for Treatment of Renal Anemia due to Chronic Kidney Disease in Non-Dialysis Patient